Serotonin receptor subtype 6 (5-HT6) is a neurotransmitter receptor, which is involved in various brain functions such as memory and mood. It mediates signaling via the interaction with a stimulatory G-protein. Especially, the third intracellular loop (iL3) of 5-HT 6 and the α subunit of stimulatory G protein (Gαs) are responsible for the signaling process of 5-HT 6 . Chemical compounds that could inhibit the interaction between the iL3 region of 5-HT 6 and Gα s were screened from a chemical library consisted of 5,600 synthetic compounds. One of the identified compounds bound to Gαs and effectively blocked the interaction between Gαs and the iL3 region of 5-HT6. The identified compound was further shown to reduce the serotonin-induced accumulation of cAMP in 293T cells transformed with 5-HT 6 cDNA. It also lowered the Ca 2+ efflux induced by serotonin in cells expressing 5-HT6 and chimeric Gαs5/q. These results indicate that the interaction between the iL3 of 5-HT6 and Gαs can be exploited for screening of regulatory compounds against the signaling pathway of 5-HT 6 .
Introduction
The neurotransmitter 5-hydroxytryptamine (5-HT), known as serotonin, is involved in various physiological functions such as learning, mood and food uptake. Improper levels of serotonin in brain are related to neurological disorders such as anxiety, depression or schizophrenia. The receptors for serotonin (5-HT1, 5-HT2, 5-HT3 and 5-HT4) have been identified from pharmacological investigation (Brandley et al., 1986; Bockaert et al., 1990; Baxter et al., 1995; Kilpatrick et al., 1991) . Moreover, three more families of serotonin receptors (5-HT5, 5-HT6 and 5-HT7) were discovered from molecular biological studies (Ree et al., 1994; Kohen et al., 1996; Jasper et al., 1997) . These serotonin receptors, except 5-HT3, belong to G-protein coupled receptors (GPCRs), and they transduce the signal via the interaction with different types of G-proteins. The stimulatory G-protein (Gs) is coupled to 5-HT4, 5-HT6 and 5-HT7 (Hoyer and Martin, 1997) , whereas inhibitory G-protein (Gi) to 5-HT1, 5-HT5 (Hoyer and Schoeffter, 1991; Francken et al., 1998) .
The serotonin receptor subtype 6 (5-HT6) has been identified from rat, mouse and human (Monsma et al., 1993; Unsworth and Molinoff, 1994; Kohen et al., 1996) . Human 5-HT6 is highly expressed in basal ganglia and limbic structure of brain (Kohen et al., 1996) . The localization of 5-HT6 to these brain tissues suggested that it might participate in the serotonergic control of motor function, mood-dependent behavior, depression, and cognition (Meneses, 2001; Rogers and Hagan, 2001; Woolley et al., 2001) . Furthermore, high binding affinities of 5-HT6 to antipsychotic agents such as chlorpromazine, amoxapine, clozapine and olanzapine, (Monsma et al., 1993; Roth et al., 1994; Kohen et al., 1996) indicated that 5-HT6 was related to the pathogenesis of psychiatric disorders. The involvement of 5-HT6 in mental function and high affinities against antipsychotic agents nominate 5-HT6 as a potential target for the development of antidepressant and antipsychotic drugs. Few antagonists that could selectively bind to An inhibitory compound against the interaction between Gα s and the third intracellular loop region of serotonin receptor subtype 6 (5-HT 6 ) disrupts the signaling pathway of 5-HT 6 5-HT6 had been developed and characterized (Boess et al., 1998; Hirst et al., 2000) .
However, selective pharmacological tools for the characterization of 5-HT6 in vivo are limited, except the use of antisense oligonucleotides that reduce the expression of the receptor (Bourson et al., 1995; Sleight et al., 1996) . Hence, discovery of new class of regulator of 5-HT6 is demanding for the investigation of in vivo function of 5-HT6 as well as for the development of novel antipsychotic drugs.
The signaling of GPCR is mediated by specific interaction with G-proteins. In case of 5-HT6, it interacts with stimulatory G protein, which results in the increase of cAMP by stimulation of adenylate cyclase (Hoyer and Martin, 1997) . Among the three subunits of G protein, the alpha subunit (G ) is responsible for the interaction with the receptor. Previously, we investigated the signaling mechanism of 5-HT6 by dissecting the interactions between G s and the intracellular regions of 5-HT6, and showed that the third intracellular loop region (iL3) of 5-HT6 specifically bound to G s using surface plasmon resonance analysis (Kang et al., 2005) .
In this study, we have tested whether the interaction between G s and the iL3 region of 5-HT6 could be exploited as target site for screening of chemical compounds that could disrupt the signaling pathway of 5-HT6. An assay system that could measure the interaction between G s and the iL3 of 5-HT6 using 96-well plate was established, and it was utilized to screen chemical library. One of the identified compounds was shown to interrupt the serotonin-induced signaling pathway in cells expressing 5-HT6.
Materials and Methods

Materials
The human cDNA library was purchased from Novagen (Madison, WI), and the 96-well polystyrene plate was obtained from Corning costar (NY). Reagents for cell culture were purchased from Gibco Ltd (Paisley, UK). All of the other chemicals were reagent grade.
Preparation of proteins
The expression vector pHG s (Kang et al., 2005) was used for the expression of H6-G s, the alpha subunit of stimulatory G protein containing N-terminus His6 tag sequence. The expression of the H6-G s was induced in E. coli BL21 (DE3) RP codon plus cells (Stratagene, La Jolla, CA) harboring pHG s by addition of 30 M isopropyl--D-thiogalactopyranoside (IPTG) for 14 h at 18 o C, and the expressed protein was purified using Ni 2+ -charged HiTrap chelating HP column (GE Healthcare, Piscataway, NJ) and Mono Q HR column as described previously (Kang et al., 2005) . The fluorescence probe labeled H6-G s was prepared by labeling the purified protein with flourescein isothiocyanate (FITC) according to the manufacturer's manual (Sigma). The expression vector pGST-iL3 was used for the preparation of GST-iL3, the glutathione S-transferase fusion protein in which the third intracellular loop of 5-HT6 (iL3; residue 209-265) was fused at the C-terminus of GST. The expression of GST-iL3 in E. coli DH5 cells was induced by adding 0.5 mM IPTG when the optical density of the culture at 600 nm (OD600) reached to 0.6. After incubation of the cell culture for 16 h at 18 o C, cells were harvested, and GST-iL3 was purified using a glutathione affinity column, GSTPrep FF 16/10 (GE Healthcare), as described previously (Kang et al., 2005) .
Measurement of the interaction between H6-Gαs and GST-iL3
The interaction between H6-G s and GST-iL3 was measured using a modified ELISA method. Briefly, H6-G s (5 g/ml) in 100 l of 50 mM phosphate buffer (pH 8.0) was incubated in a 96-well medium binding polystyrene plate (Corning costar) for overnight at 4 o C. After blocking the H6-G s coated plate with 5% of (w/v) skim milk for 1 h, the plate was washed with PBS-T (50 mM sodium phosphate, pH 7.4, 150 mM NaCl and 0.5% Tween 20) for 6 times. Then, 1 of GST-iL3 in PBS (50 mM Sodium phosphate, pH 7.4 and 150 mM NaCl) was incubated in the plate (100 l/well) for 2 h at room temperature. The unbound GST-iL3 was washed 6 times (300 l/well) with PBS-T, and the plate was incubated for 1 h in the presence of 100 l of 2,000 fold-diluted HRP conjugated anti-GST goat antibody (Sigma, St. Louis, MO). After washing the plate 6-times with PBS-T, 100 l of 1 mg/ml of OPD in the stable peroxide substrate buffer (Pierce, Rockford, IL) was added to the plate and incubated for 10 min. The color developing reaction was terminated by adding 100 l of 2.5 M sulfuric acid, and the absorbance of the reaction mixture at 490 nm was measured using a Spectra Max 340 spectrophotometer (Molecular Device Corp., Sunnyvale, CA). Alternatively, the interaction between GST-iL3 and the FITC-labeled G s was analyzed by measuring the amount of bound G protein on immobilized GST-iL3. GST-iL3 (0.5 g) in 100 l PBS-T were attached to a glutathione plate (BD Biosciences) by incubation at room temperature for 1 h. The well was washed six times with 200 l of PBS-T, and blocked with 200 l of 5% (w/v) skim milk in PBS-T for 1 h at room temperature. After washing six times with 200 l of PBS-T, the well was incubated with FITC-labeled G s (100 l/well) in buffer B for 1 h at room temperature. After washing six times with 200 l of PBST, the bound FITC-labeled G s was eluted into solution by incubation with 100 l of 8 M urea solution for 15 min. The intensity of fluorescence in the solution was measured at the excitation wavelength of 495 nm and at the emission wavelength of 525 nm using a TRIAD microplate reader (Dynex Technologies).
Screening of chemical library
The compounds of the in-house chemical library of Korea Institute of Science and Technology were tested for their inhibitory activities against the interaction between H6-G s and GST-iL3. For the screening of the library using the modified ELISA assay, 1 M of GST-iL3 fusion proteins in PBS (50 mM sodium phosphate, pH 7.4, and 150 mM NaCl) was mixed with 50 M of compound and incubated in the plate (100 l/well). Binding of HRP conjugated anti-GST goat antibody and the color development reaction were performed as described above, and the percentage of inhibition was calculated from (Ao-A)/Ao ×100 (%), where A and Ao were the absorbance values at 490 nm of the reaction mixtures with or without chemical compounds, respectively.
Measurement of the serotonin-induced stimulation of cyclic AMP in HEK 293 cells transfected with 5-HT 6 cDNA Human embryonic kidney (HEK) 293T cells were cultured in DMEM supplemented with 10% FBS, penicillin (100 IU/ml), and streptomycin (100 g/ml) in a 5% CO2 incubator at 37 o C as previously described (Byun et al., 2006) . The cells were plated onto 100-mm dishes, and they were transiently transfected with pCMV3b-5-HT6 using lipofectamine when they had reached 60-70% confluence as described in the manufacturer's instruction. After 48 h of transfection, cells were stimulated with 100 M 5-HT in the presence or absence of various concentrations of selected chemicals for 20 min. The intracellular level of cyclic AMP was determined by a [
3 H]-cyclic AMP competition method using a cAMP binding protein as described previously (Brown et al., 1971; Suh et al., 2001) .
Measurement of intracellular Ca
2+ level in CHO-K1 cells transfected with 5-HT 6 CHO-K1 cells were maintained in Nutrient F-12 Ham's medium supplied with 10% FBS, penicillin (100 U/ml), and streptomycin (100 g/ml). Cells were incubated at 37 o C in a humid atmosphere of 5% CO2 and 95% air. The human 5-HT6 (Guthrie Resource Center, Sayre, PA) and the chimeric G-protein -subunit G s5/q (from Dr. Conklin, University of California, San Francisco) were expressed in CHO-K1 cells using PolyFect (Qiagen, Germany) according to the manufacturer's protocol. The chimera protein (G s5/q) has the same sequence as G q except its C-terminal 5 amino acids were replaced by G s residues (EYNLV to QYELL). This construct allows Gs-coupled receptors to stimulate phospholipase C and subsequent intracellular Ca 2+ release (Conklin et al., 1996) . The level of Ca 2+ in cells transfected with 5-HT6 and G s5/q was measured using acetoxymethyl-ester form of fura-2 (fura-2/AM; Molecular probes, Eugene, OR), a fluorescent Ca 2+ indicator, and fluorometric imaging plate reader (Coward et al., 1999) . The effects of the compounds on the stimulated activity of 5-HT6 in transfected cells after the treatment of 100 M of serotonin were measured indirectly using chimeric G-protein. The transfected cells were treated with 100 M of serotonin, and then incubated with 5 M fura-2/AM and 0.001% Pluronic F-127 in reaction buffer (115 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 20 mM HEPES, 13.8 mM glucose, 2.5 mM probenecid and 0.1% BSA, pH 7.4) at room temperature for 1 h. After they were washed, cells were illuminated with a xenon arc lamp. The required excitation wavelengths (340 and 380 nm) were selected by a computer-controlled filter wheel (Sutter Instruments). Data were acquired every 2 s and a shutter between exposures in the light path was interposed in order to protect the cells from photo-toxicity. Emitter fluorescence was reflected through a 515 nm long-pass filter to a frame transfer cooled CCD camera. The ratios of emitted fluorescence were then calculated using a digital fluorescence analyzer and subsequently converted to an intracellular Ca 2+ concentration ([Ca 2+ ]i). All imaging data were collected and analyzed using Universal Imaging software (West Chester, PA). Tested compounds or SB258585, a potent and selective antagonist of 5-HT6, were incubated along with serotonin to examine their effect on the signaling pathway of 5-HT6.
Results
Measurement of the interaction between G s and iL3 loop region of 5-HT 6
The iL3 of 5-HT6 representing amino acid 209-265 between the 5 th and 6 th transmembrane helixes of 5-HT6 was attached at the C-terminus of GST to produce GST-iL3 ( Figure 1A ). GST-iL3 and the His-tag labeled G s (H6-G s) protein ( Figure 1B) were expressed in E. coli and purified as previously de-scribed (Kang et al., 2005) . The specific interaction between G s and iL3 of 5-HT6 was examined by a modified ELISA method using GST-iL3 and H6-G s. The amount of bound GST-iL3 increased as the concentration of GST-iL3 in the plate coated with H6-G s increased. The amount of bound GST-iL3 became saturated when the concentration of GST-iL3 was 2 M or higher (Figure 2 ). When GST was applied to the plate coated with H 6 -G s , negligible amount of GST was detected (Figure 2 , open circle). The dissociation constant (KD) was calculated as 0.5×10
M from the binding curve of GST-iL3. These results indicated that GST-iL3 specifically bound to the immobilized H 6 -G S via the interaction between the iL3 region of the fusion protein and G s . The modified ELISA method was further applied for the screening of chemical library for potential inhibitors against the interaction between 5-HT 6 and G s .
Screening of chemical compounds that block the interaction between G s and iL3 of 5-HT 6 receptor A chemical library consisted of 5,600 compounds was screened to identify inhibitory compounds against the interaction between G s and the iL3 region of 5-HT6 using the modified ELISA method. About 40 compounds that could inhibit more than 50% of the binding of GST-iL3 to immobilized H6-G s were identified from primary screening. The inhibitory activities of these compounds were further examined by the modified ELISA method, and 3 compounds that could effectively inhibit the interaction between with GST-iL3 and H6-G s were selected. The concentration dependent inhibitory activities of KKJ00016, KKJ00583 and KYS00423 were measured ( respectively.
Inhibition of serotonin induced cAMP production by KKJ00016 and KYS00423
The three compounds selected from the primary screening of the chemical library were further tested whether they could disrupt the signaling pathway of 5-HT6. To examine the effect of the isolated compounds on the serotonin-induced production of cellular cAMP, HEK293T cells transformed with 5-HT6 were treated with the compounds, and then the amount of cAMP produced by the treatment of 5-HT was measured. The treatment of serotonin activated the 5-HT6 in the transformed HEK293T cells and stimulated the production of cAMP ( Figure 4A ). When the transfected cells were treated with 20 M of KKJ00016, KKJ00583 or KYS00423, only KKJ-00016 significantly reduced the levels of cAMP. The induction of cAMP in KKJ00016-treated cells was 50% compared to un-treated cells, and KYS00423 only marginally reduced the level of cAMP ( Figure  4A ). In contrast, KKJ00583 rather enhanced the level of cAMP (data not shown). The inhibitory activity of KKJ00016 on the serotonin-induced production of cAMP was further examined at various concentrations. As the concentration of KKJ00016 increased, the level of cAMP induced by serotonin decreased, and the IC50 value of KKJ00016 in this assay system was calculated about 15 M ( Figure 4B ). These results indicated that KKJ0016 that could block the interaction between the iL3 of 5-HT6 and G s, and it also prevented the serotonin-induced production of cAMP in the cell transfected with 5-HT6.
KKJ00016 and KYS00423 bind to G s rather than the iL3 region of 5-HT 6 To investigate the inhibitory mechanism of the identified compounds, the proteins bound to the compounds were examined. Immobilized GST-iL3 on glutathione plate was pretreated with 20 M of KKJ-00016 or KYS00423 and incubated with FITC-labeled G s after washing the unbound compounds. Then, the amount of bound G s was measured and compared to the bound G s from the incubation mixture in the presence or absence of the compounds. As shown in Figure 4 , the binding of H 6 -G s to GST-iL3 is effectively prevented by KKJ00016 or KYS00423 ( Figure 5, black boxes) . However, pretreatment of these compounds to GST-iL3 failed to prevent the interaction between GST-iL3 and H 6 -G s ( Figure 5, grey boxes) . These results indicate that KKJ00016 or KYS00423 binds to G s rather than GST-iL3 and prevents the interaction between G s and GST-iL3.
Inhibition of serotonin induced Ca
2+ signaling by KKJ00016 The inhibitory activity of KKJ00016 on the signaling pathway of 5-HT6 was also examined using cells ex- pressing a chimeric G protein, G s5/q. The chimera protein interacted with GPCRs coupled with Gs protein and increased the cellular level of calcium ion. The cells transfected both with the gene of G s5/q and 5-HT6 showed increased Ca 2+ level when they were activated by serotonin (Table 1) . When the cells were treated with SB258585, the antagonist of 5-HT6 (Hirst et al., 2000) , the Ca 2+ efflux induced by serotonin was effectively inhibited indicating that the signaling pathway of 5-HT6 was coupled with the chimera G s5/q in the transfected cells. When the cells were treated with KKJ00016, the serotonin induced Ca 2+ efflux was substantially inhibited (Table 1) . About 37% of Ca 2+ level was reduced at 10 M of KKJ00106. These results indicated that KKJ00016 could interfere the signaling pathway of 5-HT6, by inhibiting the activation of Gs protein.
Discussion
The interaction between the intracellular region of receptor and G-protein has been exploited for the screening of small molecule regulators of 5-HT6 signaling pathway. Among the intracellular regions of 5-HT6, the iL3 was identified as a critical region for the interaction with G s, whereas the second intracellular region between the transmembrane helix 3 and 4 or the C-terminus region failed to bind to the G s (Kang et al., 2005) . The dissociation constant of iL3 on the G s (KD = 0.5×10 -6 M) obtained by a modified ELISA method in this study was comparable to the previously obtained value (KD = 0.9×10 -6 M) by surface plasmon resonance analysis (Kang et al., 2005) . Glutathione sepharose bead and GST-fusion protein had been used to measure the protein interaction in vitro (Kim et al., 2006) . However, this method is inadequate for screening large number of chemical compounds. In contrast, the modified ELISA method in this study could be adapted in 96-well plate system and applied for the screening of chemical library for potential inhibitors against the interaction between iL3 of 5-HT6 and G s. The identified compounds in this study were shown to interact with G s since the compounds pretreated with GST-iL3 were easily washed out and failed to prevent the interaction with G s (Figure 4) . The direct binding of these compounds to G s was further confirmed by co-elution of these compounds along with H6-G s in size exclusion chromatography. When the mixture of H6-G s and KKJ00016 or KYS00423 was separated using desalting column, KKJ00016 or KYS00423 was detected in the protein fractions by thin layer chromatography. However, they were not detected in the protein fraction when they were mixed with GST-iL3 (data not shown).
One of the identified compounds from the primary *Inhibition effects of the compounds were compared to the inhibitory activity of SB258585, a potent antagonist. The inhibitory activities were determined using the maximum change in fluorescence over baseline. All data represent the mean of duplicate determinations from a typical experiment which was repeated at least more than 10 times. screening was shown to interrupt the signaling of 5-HT6. KKJ00016 prevented the accumulation of cAMP induced by serotonin in 5-HT6 transfected cells with IC50 value of 15 M, which was comparable to the IC50 value (8 M) measured from the modified ELISA method. Also, 10 M of KKJ00016 inhibited about 37% of Ca 2+ efflux in cells transfected with 5-HT6 and chimera G protein, which triggers Ca 2+ -efflux after stimulation of serotonin. The similar ranges of the inhibitory concentrations of KKJ00016 in different assay systems imply that the disruption of the interaction between 5-HT6 and Gs protein is directly related to the interference of the signaling pathway of 5-HT6. The GPCRs, activated by ligands, induce the exchanges of GDP for GTP on G subunit. The activated G -GTP dissociates from the G subunits and activates its downstream effectors. Chemicals that interfere with the interaction between GPCR and G-protein may perturb this signaling pathway and abolish the ligand-dependent activation of G-protein.
It should be noted that KKJ00016 is a derivative of cephalosporin containing aminothiazole and triazole groups (Figure 6 ), which has different structure of SB258585, an antagonist of 5-HT6 (Hirst et al., 2000) . Since KKJ00016 binds G s rather than the serotonin-binding site of 5-HT6, KKJ00016 was expected to have different structures than the general antagonist or agonists of 5-HT receptors. It should be noted that G s mediates signaling of 5-HT6 as well as 5-HT4, 5-HT7 or other G-protein coupled receptors. Hence, direct application of KKJ00016 as inhibitor of 5-HT6 will be limited due to the possible non-specific disruption of G s mediated signaling pathway, although KKJ00016 could inhibit serotonin-induced signaling pathway of 5-HT6 (Figure 4) . However, the assay system targeted the interaction between the iL3 of 5-HT6 and G s could applied to screen chemical compounds that show specificity to the iL3 region of 5-HT6.
In this study, we have identified chemical compounds that could block the specific interaction between 5-HT6 and G s using a convenient assay system that measuring the interaction between iL3 of 5-HT6 and G s. The inhibitory activities of the identified compound on the serotonin-induced production of cAMP suggested that the specific interaction between 5-HT6 and G s could serve as a novel target site for developing 5-HT6 regulators. Interference of the interaction between GPCR and G-protein would have advantages compared to the classical antagonist or agonist of GPCR targeted to the ligand binding site. This approach may generate subtype-specific drugs which could be difficult to obtain. Also high resolution structure of the G-protein and intracellular loop complex would be used to design high affinity inhibitors that block the signaling process of GPCRs.
